Borrelli, K. N., Wingfield, K. K., Yao, E. J., Zamorano, C. A., Sena, K. D., Beierle, J. A., Roos, M. A., Zhang, H., Wachman, E. M., & Bryant, C. D. (2023). Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW MICE. Neuropharmacology, 240, 109732. https://doi.org/10.1016/j.neuropharm.2023.109732

Beierle, J. A., Yao, E. J., Goldstein, S. I., Lynch, W. B., Scotellaro, J. L., Sena, K. D., Wong, A. L., Linnertz, C. A., Averin, O., Moody, D. E., Reilly, C. A., Peltz, G., Emili, A., Ferris, M. T., & Bryant, C. D. (2022). Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward. https://doi.org/10.1101/2022.03.18.484877

Sena, K. D., Beierle, J. A., Richardson, K. T., Kantak, K. M., & Bryant, C. D. (2022). Assessment of binge-like eating of unsweetened vs. sweetened chow pellets in BALB/C substrains. Frontiers in Behavioral Neuroscience, 16. https://doi.org/10.3389/fnbeh.2022.944890

Borrelli, K. N., Wachman, E. M., Beierle, J. A., Taglauer, E. S., Jain, M., Bryant, C. D., & Zhang, H. (2022). Effect of prenatal opioid exposure on the human placental methylome. Biomedicines, 10(5), 1150. https://doi.org/10.3390/biomedicines10051150

Beierle, J. A., Yao, E. J., Goldstein, S. I., Scotellaro, J. L., Sena, K. D., Averin, O., Moody, D. E., Reilly, C. A., Emili, A., Peltz, G., Ferris, M. T., & Bryant, C. D. (2022). A reduced complexity cross between BALB/C substrains identifies ZHX2 as a candidate gene underlying oxycodone metabolite brain concentration and state‐dependent learning of opioid reward. The FASEB Journal, 36(S1). https://doi.org/10.1096/fasebj.2022.36.s1.r4573

Beierle, J. A., Yao, E. J., Goldstein, S. I., Scotellaro, J. L., Sena, K. D., Linnertz, C. A., Willits, A. B., Kader, L., Young, E. E., Peltz, G., Emili, A., Ferris, M. T., & Bryant, C. D. (2022). Genetic basis of thermal nociceptive sensitivity and brain weight in a BALB/C reduced complexity cross. Molecular Pain, 18, 174480692210795. https://doi.org/10.1177/17448069221079540

Goldberg, L. R., Yao, E. J., Kelliher, J. C., Reed, E. R., Cox, J. W., Parks, C., Kirkpatrick, S. L., Beierle, J. A., Chen, M. M., Johnson, W. E., Homanics, G. E., Williams, R. W., Bryant, C. D., & Mulligan, M. K. (2021). A Quantitative Trait Variant inGabra2Underlies Increased Methamphetamine Stimulant Sensitivity. https://doi.org/10.1101/2021.06.29.450337

Borrelli, K. N., Yao, E. J., Yen, W. W., Ruan, Q. T., Chen, M. M., Kelliher, J. C., Langan, C. R., Scotellaro, J. L., Babbs, R. K., Beierle, J. C., Logan, R. W., Johnson, W. E., Wachman, E. M., Cruz-Martín, A., & Bryant, C. D. (2021). Sex differences in behavioral and brainstem transcriptomic neuroadaptations following neonatal opioid exposure in outbred mice. Eneuro, 8(5). https://doi.org/10.1101/2021.04.02.438265

Kantak, K. M., Stots, C., Mathieson, E., & Bryant, C. D. (2021). Spontaneously hypertensive rat substrains show differences in model traits for addiction risk and cocaine self-administration: Implications for a novel Rat Reduced Complexity Cross. Behavioural Brain Research, 411, 113406. https://doi.org/10.1016/j.bbr.2021.113406

Ruan, Q. T., Lynch, W. B., Cole, R. H., Rieger, M. A., Beierle, J. A., Yao, E. J., Cox, J. W., Kandola, A., Richardson, K. T., Chen, M. M., Kelliher, J. C., Babbs, R. K., Ash, P. E., Wolozin, B., Szumlinski, K. K., Johnson, W. E., Dougherty, J. D., & Bryant, C. D. (2021). CACNA2D2 Is an Hnrnp h Target of the Striatal Mrna Targetome and Regulates Methamphetamine Behavior. https://doi.org/10.1101/2021.07.06.451358

Ruan, Q. T., Yazdani, N., Blum, B. C., Beierle, J. A., Lin, W., Coelho, M. A., Fultz, E. K., Healy, A. F., Shahin, J. R., Kandola, A. K., Luttik, K. P., Zheng, K., Smith, N. J., Cheung, J., Mortazavi, F., Apicco, D. J., Ragu Varman, D., Ramamoorthy, S., Ash, P. E. A., Rosene, D. L., … Bryant, C. D. (2020). A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins. The Journal of neuroscience : the official journal of the Society for Neuroscience, 40(1), 107–130. https://doi.org/10.1523/JNEUROSCI.1808-19.2019

Yao, E. J., Babbs, R. K., Kelliher, J. C., Luttik, K. P., Borrelli, K. N., Damaj, M. I., Mulligan, M. K., & Bryant, C. D. (2021). Systems genetic analysis of binge-like eating in a C57BL/6J x DBA/2J-F2 cross. Genes, brain, and behavior, e12751. Advance online publication. https://doi.org/10.1111/gbb.12751

Borrelli, K. N., Langan, C. R., Dubinsky, K. R., Szumlinski, K. K., Carlezon, W. A., Jr, Chartoff, E. H., & Bryant, C. D. (2021). Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant mice. Psychopharmacology, 238(7), 2031–2041. https://doi.org/10.1007/s00213-021-05829-4

Damaj, M. I., McKiver, B., Mann, J., Yao, E. E., & Bryant, C. (2021, March). Genetic variation in paclitaxel-induced peripheral neuropathy in mice. In JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (Vol. 26, No. 1, pp. 131-132). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.

Bryant, C. D., Healy, A. F., Ruan, Q. T., Coehlo, M. A., Lustig, E., Yazdani, N., Luttik, K. P., Tran, T., Swancy, I., Brewin, L. W., Chen, M. M., & Szumlinski, K. K. (2021). Sex-dependent effects of an Hnrnph1 mutation on fentanyl addiction-relevant behaviors but not antinociception in mice. Genes, brain, and behavior, 20(3), e12711. https://doi.org/10.1111/gbb.12711

Bryant, C. D., Smith, D. J., Kantak, K. M., Nowak, T. S., Jr, Williams, R. W., Damaj, M. I., Redei, E. E., Chen, H., & Mulligan, M. K. (2020). Facilitating Complex Trait Analysis via Reduced Complexity Crosses. Trends in genetics : TIG, 36(8), 549–562. https://doi.org/10.1016/j.tig.2020.05.003

Ruan, Q. T., Yazdani, N., Reed, E. R., Beierle, J. A., Peterson, L. P., Luttik, K. P., Szumlinski, K. K., Johnson, W. E., Ash, P. E. A., Wolozin, B., & Bryant, C. D. (2020). 5′ UTR variants in the quantitative trait gene Hnrnph1 support reduced 5′ UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 34(7), 9223–9244. https://doi.org/10.1096/fj.202000092R

Babbs, R. K., Beierle, J. A., Yao, E. J., Kelliher, J. C., Medeiros, A. R., Anandakumar, J., Shah, A. A., Chen, M. M., Johnson, W. E., & Bryant, C. D. (2020). The effect of the demyelinating agent cuprizone on binge-like eating of sweetened palatable food in female and male C57BL/6 substrains. Appetite, 150, 104678. https://doi.org/10.1016/j.appet.2020.104678

Bryant, C. D., Healy, A. F., Ruan, Q. T., Coehlo, M. A., Lustig, E., Yazdani, N., Luttik, K. P., Tran, T., Swancy, I., Brewin, L. W., Chen, M. M., & Szumlinski, K. K. (2020). Fentanyl-induced antinociception, reward, reinforcement, and withdrawal in hnrnph1 mutant mice. Biorxiv. https://doi.org/10.1101/2020.06.06.137158

Ruan, Q. T., Yazdani, N., Blum, B. C., Beierle, J. A., Lin, W., Coelho, M. A., Fultz, E. K., Healy, A. F., Shahin, J. R., Kandola, A. K., Luttik, K. P., Zheng, K., Smith, N. J., Cheung, J., Mortazavi, F., Apicco, D. J., Ragu Varman, D., Ramamoorthy, S., Ash, P. E. A., Rosene, D. L., … Bryant, C. D. (2020). A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins. The Journal of neuroscience : the official journal of the Society for Neuroscience, 40(1), 107–130. https://doi.org/10.1523/JNEUROSCI.1808-19.2019

Babbs, R. K., Beierle, J. A., Kelliher, J. C., Medeiros, R., Anandakumar, J., Shah, A., Yao, E. J., Chen, M. M., & Bryant, C. D. (2019). The demyelinating agent cuprizone induces a male-specific reduction in binge eating in the binge-prone C57BL/6NJ strain. Biorxiv. https://doi.org/10.1101/865600

Babbs, R. K., Beierle, J. A., Ruan, Q. T., Kelliher, J. C., Chen, M. M., Feng, A. X., Kirkpatrick, S. L., Benitez, F. A., Rodriguez, F. A., Pierre, J. J., Anandakumar, J., Kumar, V., Mulligan, M. K., & Bryant, C. D. (2019). Cyfip1 Haploinsufficiency Increases Compulsive-Like Behavior and Modulates Palatable Food Intake in Mice: Dependence on Cyfip2 Genetic Background, Parent-of Origin, and Sex. G3 (Bethesda, Md.), 9(9), 3009–3022. https://doi.org/10.1534/g3.119.400470

Mulligan, M. K., Abreo, T., Neuner, S. M., Parks, C., Watkins, C. E., Houseal, M. T., Shapaker, T. M., Hook, M., Tan, H., Wang, X., Ingels, J., Peng, J., Lu, L., Kaczorowski, C. C., Bryant, C. D., Homanics, G. E., & Williams, R. W. (2019). Identification of a Functional Non-coding Variant in the GABA _A Receptor α2 Subunit of the C57BL/6J Mouse Reference Genome: Major Implications for Neuroscience Research. Frontiers in genetics, 10, 188. https://doi.org/10.3389/fgene.2019.00188

Babbs RK, Beierle JA, Ruan QT, Kelliher JC, Feng AX, Kirkpatrick SL, Benitez FA, Rodriguez FA, Pierre J, Kumar V, Mulligan MK, Bryant CD (2018).  Cyfip1 haploinsufficiency increases compulsive-like behavior and paternally inherited palatable food intake: Implications for hyperphagia in Prader-Willi Syndrome. Revised manuscript under review, https://doi.org/10.1101/264846

Ruan, Q. T., Yazdani, N., Beierle, J. A., Hixson, K. M., Hokenson, K. E., Apicco, D. J., Luttik, K. P., Zheng, K., Maziuk, B. F., Ash, P. E. A., Szumlinski, K. K., Russek, S. J., Wolozin, B., & Bryant, C. D. (2018). Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation. Neuroscience letters, 684, 109–114. https://doi.org/10.1016/j.neulet.2018.07.015

Rodriguez FA, Pierre J, Kumar V, Mulligan MK, Bryant CD (2018).  Cyfip1 haploinsufficiency increases compulsive-like behavior and paternally inherited palatable food intake: Implications for hyperphagia in Prader-Willi Syndrome. Revised manuscript under review, https://doi.org/10.1101/264846

Bryant CD*, Bagdas D, Khalefa T, Goldberg LR, Reed ER, Kirkpatrick SL, Kelliher JC, Chen MM, Johnson WE, Mulligan MK, Damaj MI (2018). C57BL/6 substrain differences in inflammatory nociception and genetic mapping of a major quantitative trait locus underlying acute thermal nociception, Under review, https://www.biorxiv.org/content/early/2018/09/10/413856

Babbs RK*, Kelliher JC*, Scotellaro JL, Yazdani N, Ruan QT, Mulligan, MK, Bryant CD (2018). Genetic differences in the behavioral organization of binge eating, conditioned food reward, and compulsive-like eating C57BL/6J and DBA/2J strains. Accepted, Physiology and Behavior, https://doi.org/10.1101/190827

Ruan QT*, Yazdani N*, Beierle JA, Hixson KM, Hokensen KE, Appico DJ, Luttik KP, Zheng K, Ash PEA, Szumlinski KK, Russek SJ, Wolozin B, Bryant CD (2018). Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation. Neuroscience Letters, 684: 109-114.

Bryant CD, Ferris MT, Manuel de Villena FPM, Damaj MI, Kumar V, Mulligan MK (2018). Ch. 14: Reduced complexity cross design for behavioral genetics. Molecular-Genetic and Statistical Techniques for Behavioral and Neural Research. Publication date: June 2018. Edited by Wim E. Crusio and Robert T. Gerlai

Apicco DJ, Ash PE, Maziuk B, LeBlang C, Medalla M, Al Abdullatif A, Ferragud Faus A, Botelho E, Balance HI, Dhawan U, Boudeau S, Kashy D, Wong A, Goldberg LR, Yazdani N, Zhang C, Choong YU, Tripodis Y, Kanaan NM, Ikezu T, Cottone P, Leszyk J, Li H, Luebke J, Bryant CD, Wolozin B (2018). Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo, Nature Neuroscience, 21(1): 72-80.

Goldberg LR, Kirkpatrick SL, Yazdani N, Luttik KP, Lacki OA, Babbs RK, Jenkins DF, Johnson WE, Bryant CD (2017). Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating. Accepted, Genes, Brain and Behavior

Kirkpatrick SL, Goldberg LR, Yazdani N, Babbs RK, Wu J, Reed ER, Jenkins DF, Bolgioni AF, Landaverde KI, Luttik KP, Mitchell KS, Kumar V, Johnson WE, Mulligan MK, Cottone P, Bryant CD (2017). Cytoplasmic FMR1-interacting protein 2 is a major genetic factor underlying binge eating. Biological Psychiatry, 81(9): 757-769.

Young EE, Bryant CD, Lee SE, Peng X, Cook B, Nair HK, Dreher KJ, Zhang X, Palmer AA, Chung JM, Mogil JS, Chesler EJ, Lariviere WR (2016). Systems genetic and pharmacological analysis identifies candidate genes underlying mechanosensation in the Von Frey test. In press, Genes, Brain and Behavior.

Yazdani N, Shen Y, Johnson WE, Bryant CD (2016). Striatal transcriptome analysis of a congenic mouse line (chromosome 11: 50-60 Mb) exhibiting a reduced locomotor stimulant response to methamphetamine. Genomics Data. June, 8: 77-80, doi: 10.1016/j.gdata.2016.03.009

Bryant CD, Yazdani N (2016). RNA binding proteins, neural development and the addictions. Genes, Brain and Behavior 15: 169-186.

Yazdani N, Parker CC, Shen Y, Reed ER, Guido MA, Kole LA, Kirkpatrick SL, Lim JE, Sokoloff G, Cheng R, Johnson WE, Palmer AA, Bryant CD (2015). Hnrnph1 is a quantitative trait gene for methamphetamine sensitivity. PLOS Genetics 11(12):e1005713.

Kirkpatrick, S. L., & Bryant, C. D. (2015). Behavioral architecture of opioid reward and aversion in C57BL/6 substrains. Frontiers in Behavioral Neuroscience, 8, 450. doi:10.3389/fnbeh.2014.0045

Zhou L, Bryant CD, Loudon AS, Palmer AA, Vitaterna MH, Turek FW (2014).  The circadian clock gene Csnk1e regulates REM sleep and NREM sleep architecture in mice. Sleep, 37(4): 785-93.

Bryant CD, Guido MA, Kole LA, Cheng R.  The heritability of oxycodone reward and concomitant phenotypes in a LG/J x SM/J F48 mouse advanced intercross line (2014). Addiction Biology, 19(4): 552-561

Publications from before Dr. Bryant joined BU

Bryant CD, Kole LA, Guido MA, Cheng R, Palmer AA (2012).  Methamphetamine-induced conditioned place preference in LG/J and SM/J mouse strains and an F₄₅/F₄₆ advanced intercross line. Frontiers in Genetics 3:126

Bryant CD, Kole LA, Guido MA, Sokoloff G, Palmer AA (2012). Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis. Genes, Brain and Behavior 11(5):623-32

Bryant CD, Parker CC, Zhou L, Olker C, Chandrasekaran RY, Wager TT, Bolivar VJ, Loudon AS, Vitaterna MH, Turek FW, Palmer AA (2012). Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids. Neuropsychopharmacology 37(4):1026-35.

Bryant CD, Chang HP, Zhang J, Wiltshire T, Tarantino LM, Palmer AA (2009). A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice. Genes, Brain and Behavior 8(8):795-805.

Hofford RS, Hodgson SR, Roberts KW, Bryant CD, Evans CJ, Eitan S (2009). Extracellular signal-regulated kinase activation in the amygdala mediates elevated plus maze behavior during opioid withdrawal. Behavioural Pharmacology 20(7):576-583.

Bryant CD, Roberts KW, Culbertson CS, Le A, Evans CJ, Fanselow MS (2009). Pavlovian conditioning of multiple opioid-like responses in mice. Drug and Alcohol Dependence 103:74-83.

Bryant CD, Graham ME, Distler MG, Munoz MB, Li D, Vezina P, Sokoloff G, Palmer AA (2009). A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology 203(4):703-11.

Bryant CD, Zhang NN, Sokoloff G, Fanselow MS, Ennes HS, Palmer AA, McRoberts JA (2008). Behavioral differences among C57BL/6 substrains:  Implications for transgenic and knockout studies. Journal of Neurogenetics 22(4):315-31.

Gioiosa L, Chen X, Watkins R, Klanfer N, Bryant CD, Evans CJ, Arnold AP (2008). Sex chromosome complement affects nociception in tests of acute and chronic exposure to morphine in mice. Hormones and Behavior 53(1):124-13

Bryant CD, Roberts KW, Byun JS, Fanselow, MS, Evans CJ (2006). Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice. Pharmacology, Biochemistry and Behavior 85(4):769-79.

Bryant CD, Eitan S, Sinchak K, Fanselow MS, Evans CJ (2006). NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice. American Journal of Physiology:  Regulatory, Comparative and Integrative Physiology 292(2):R315-R326.

Lutfy K, Eitan S, Bryant CD, Yang YC, Walwyn W, Saliminejad N, Kieffer BL, Takeshima H, Carroll FI, Maidment  NT, and Evans CJ (2003).  Buprenorphine-induced antinociception is mediated by mu receptors and compromised by concomitant activation of opioid-like receptor-1 receptors. Journal of Neuroscience 23(32):10331-7.

Eitan S, Bryant CD, Saliminejad N, Yang YC, Vojdani E, Polakiewicz R, Evans CJ (2003). Brain region-specific mechanisms of morphine-induced MAPK modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. Journal of Neuroscience 23(23):8360-9.

Wilson SG*, Bryant CD*, Lariviere WR, Olsen MS, Giles BE, Chesler EJ, Mogil JS (2003). The heritability of antinociception II: Pharmacogenetic mediation of three over-the-counter analgesics in mice. Journal of Pharmacology and Experimental Therapeutics 305(2):755-64

Bryant CD, Zaki PA, Carroll FI, Evans CJ (2005). Opioids and Addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes. Clinical Neuroscience Research 5:103-115. Review